ANTI-NMDAR ENCEPHALITIS
Clinical trials for ANTI-NMDAR ENCEPHALITIS explained in plain language.
Never miss a new study
Get alerted when new ANTI-NMDAR ENCEPHALITIS trials appear
Sign up with your email to follow new studies for ANTI-NMDAR ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Brain-Attacking antibodies in severe encephalitis
Disease control Recruiting nowThis study tests whether combining two drugs—ofatumumab and daratumumab—can safely and effectively treat people with severe anti-NMDAR autoimmune encephalitis, a condition where the immune system attacks the brain. The drugs aim to eliminate the harmful immune cells producing the…
Matched conditions: ANTI-NMDAR ENCEPHALITIS
Phase: PHASE3 • Sponsor: The First People's Hospital of Changzhou • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Hunting for hidden antibodies in brain inflammation
Knowledge-focused Recruiting nowThis study aims to better understand autoimmune encephalitis, a condition where the immune system attacks the brain. Researchers will analyze blood and spinal fluid from 20 patients to find new antibodies that may explain the disease in people who currently test negative. The goa…
Matched conditions: ANTI-NMDAR ENCEPHALITIS
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC